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Abstract: Intraperitoneal insufflation of carbon dioxide may affect the
sympathetic activity that leads to changes in ventricular repolarization.
This in turn can result in changes of heart rate-corrected QT (QTc)
interval and Tpeak–Tend (Tp-e) interval. Dexmedetomidine is a highly
selective a2-receptor agonist and has potential antiarrhythmic proper-
ties. This prospective, randomized, double-blinded, controlled study
evaluated the effects of dexmedetomidine administration on QTc and
Tp-e intervals during robot-assisted laparoscopic prostatectomy with
steep Trendelenburg position.
Fifty patients scheduled for robot-assisted laparoscopic prostatectomy
randomly received either a continuous infusion of dexmedetomidine at a
rate of 0.3mg/kg/hour, from anesthetic induction until the end of the
Trendelenburg position (dexmedetomidine group; n¼ 25), or the same
volume of normal saline (control group; n¼ 25). Anesthesia was main-
tained with sevoflurane and remifentanil. The primary and secondary
goalswere to evaluate the effect of dexmedetomidineon theQTc andTp-e
interval changes. Mean arterial pressure, heart rate, end-tidal CO2, and
end-tidal sevoflurane concentrations were assessed as well.
Forty-seven patients (94%) completed the study. Dexmedetomidine
significantly attenuated QTc interval prolongation and reduced the Tp-e
interval, even though the baseline values of the QTc and Tp-e intervals
were similar between the 2 groups (PGroup Time¼ 0.001 and 0.014,
respectively). Twenty-two patients (96%) in the control group and 13
(54%) in the dexmedetomidine group had QTc interval prolongation of
>20ms from the baseline value during surgery (P¼ 0.001). The maxi-
mum QTc interval prolongation from the baseline value during surgery
was 46 21ms in the control group and 24 21ms in the dexmedeto-
midine group (meanSD, P¼ 0.001). Mean arterial pressure and heartJae Chul Koh, MD , MD, PhD,
MD, and So Yeon Kim, MD, PhD
pneumoperitoneum with steep Trendelenburg position. Furthermore,
dexmedetomidine reduced the Tp-e interval. Thus, dexmedetomidine
administration may be effective for patients who are susceptible to
the development of ventricular arrhythmia during robot-assisted
laparoscopic prostatectomy.
(Medicine 95(19):e3645)
Abbreviations: CO2 = carbon dioxide, ECG = electrocardiography,
EtCO2 = end-tidal CO2, HR = heart rate, MAP = mean arterial
pressure, QTc = heart-rate corrected QT, Tp-e = Tpeak–Tend.
INTRODUCTION
I ntraperitoneal insufflation of carbon dioxide (CO2) is themost commonly used method for adequate surgical access
during laparoscopic surgery. However, CO2 pneumoperitoneum
may influence autonomic nervous activity, resulting in sym-
pathetic hyperactivity and alterations in circulatory hemody-
namics due to increased intraabdominal pressure.1–5 In fact,
cardiac arrhythmias such as sinus tachycardia, ventricular
tachycardia, and asystole have been reported during CO2 pneu-
moperitoneum.6 Robot-assisted laparoscopic prostatectomy
requires a steep Trendelenburg position in addition to CO2
pneumoperitoneum. The combination of the 2 may induce
significant cardiovascular changes, and an increase in head-
down angle may further augment these changes.7,8
The stimulation of sympathetic activity provokes changes
in cardiac repolarization,9,10 which can result in changes in the
values of the indexes of ventricular repolarization, such as
heart rate (HR)-corrected QT (QTc) interval and Tpeak–Tend
(Tp-e) interval.11–14 Prolongation of the QTc and Tp-e inter-
vals can lead to malignant ventricular arrhythmias such as
torsades de pointes and even sudden cardiac death.14–17 QTc
interval prolongation was reported in laparoscopic cholecys-
tectomy, and the prolongation was significantly greater in
the elderly than in the younger patients.18 Most patients
who undergo prostatectomy are elderly with various comor-
bidities. However, no study has evaluated the changes in
QTc and Tp-e intervals during robot-assisted laparoscopic
prostatectomy.
Dexmedetomidine is a highly selective a2-receptor ago-
nist that has sympatholytic, analgesic, and sedative properties.19
Apart from these properties, dexmedetomidine has potential
antiarrhythmic properties and was reported to be effective in the
prevention and treatment of perioperative tachyarrhythmia inery.20,21 Furthermore, dexmedetomidine
erval prolongation during tracheal intu-
thesia.22,23
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Thus, in this randomized, double-blind, placebo-controlled
Kim et alstudy, we evaluated the effect of dexmedetomidine on QTc and
Tp-e intervals during robot-assisted laparoscopic prostatectomy
with steep Trendelenburg position.
METHODS
After acquiring approval from the Institutional Review
Board and Hospital Research Ethics Committee of Severance
Hospital, Yonsei University Health System, Seoul, Korea
(IRB protocol No. 4-2015-0337), clinical trial registration
was obtained at http://clinicaltrials.gov (registration No.
NCT02536014). Between August, 2015 and January, 2016,
50 male patients with an American Society of Anesthesiologists
physical status of I/II who were scheduled to undergo robot-
assisted laparoscopic prostatectomy were enrolled, after written
informed consents were obtained from all the patients. Patients
were excluded if any of the following criteria were present:
emergency surgery; preoperative electrocardiography (ECG)
abnormalities, including a QTc interval of>440 ms, ventricular
conduction abnormalities, or arrhythmias; history of cardiac
disease such as pacemaker insertion, unstable angina, conges-
tive heart failure, or valvular heart disease; use of antiarrhyth-
mic agents or medications other than antihypertensive agents
that are known to prolong the QTc interval; abnormal levels of
preoperative serum electrolytes; concomitant hepatic or renal
failure; any allergy or hypersensitivity to a2-adrenergic ago-
nists; and neurological or psychiatric impairment.
The patients were randomly allocated to either the dex-
medetomidine group (n¼ 25) or the control group (n¼ 25)
according to the computer-generated random numbers (http://
www.random.org). In the dexmedetomidine group, dexmede-
tomidine (100mg/mL in a 2 mL-vial; Hospira Worldwide,
Seoul, Korea) was administered at a rate of 0.3mg/kg/hour,
from anesthetic induction until the end of the Trendelenburg
position. Dexmedetomidine 200mg was diluted with normal
saline to a total volume of 50 mL in order to make a concen-
tration of 4mg/mL. The control group received volume-
matched normal saline infusion as placebo. Dexmedetomidine
or normal saline was prepared by an anesthesiologist who did
not participate in the data collection. The investigator, surgeons,
attending anesthesiologist, recovery nurses, and patients were
blinded to the group allocation.
Upon arrival to the operating room, 0.1 mg of glycopyrro-
late was given intravenously as a premedication. In all the
patients, ECG, oxygen saturation analysis, noninvasive arterial
blood pressure monitoring, and bispectral index monitoring
(Aspect A-2000; Aspect Medical System Inc., Newton, MA)
were performed. Anesthesia was induced with propofol 1.5 to
2 mg/kg, remifentanil 0.5mg/kg, and rocuronium 1.2 mg/kg.
Mechanical ventilation was maintained at a tidal volume of 8
to 10 mL/kg and a positive end-expiratory pressure of 5 cm H2O.
The respiratory rate was adjusted to maintain the end-tidal CO2
(EtCO2) at 35 to 45 mm Hg in 50% O2/air. After induction, a
radial artery catheter was placed and arterial pressure was
continuously monitored. Anesthesia was maintained with sevo-
flurane (0.7–1.2 age-adjusted minimal alveolar concentration)
and remifentanil (0.02–0.1mg/kg/min) by targeting bispectral
index scores between 40 and 60.
The QT and Tp-e intervals from continuous ECG monitor-
ing in lead V5 were collected by using the LabChart software
(Pro Version 7: AD Instruments, CO., Sydney, Australia) and a
data acquisition system (PowerLab; AD Instruments). The QT
(onset of the QRS complex to the end of the T wave) and Tp-e
2 | www.md-journal.comintervals (from the peak to the end of the Twave) were measured
at the following 9 separate time points automatically via lead
V5: before induction of anesthesia in the supine position
(Baseline); 10 minutes after tracheal intubation (Intu-10 min);
immediately after steep Trendelenburg position with CO2 pneu-
moperitoneum (T-on); 30; 60; and 90 minutes after steep Tren-
delenburg position with CO2 pneumoperitoneum (T-30 min,
T-60 min, and T-90 min); immediately after a supine position
with CO2 desufflation (T-off); at the end of surgery (Surgery
end); and 60 minutes after a supine position with CO2 desuf-
flation in the postanesthetic care unit (T-off 60 min). If the
automatic measurement did not correctly detect the earliest
onset of the QRS complex or the end of the T wave, the QT and
Tp-e intervals were measured manually by using the cursor
from the earliest onset of the QRS complex or the highest
amplitude of the Twave to the latest end of the Twave, where its
terminal limb joined the baseline.23 The recorded measurements
of QTand Tp-e intervals were averaged from 4 successive beats.
The QT interval was corrected for HR by using the Bazett
formula,
QTc ¼ QT=
ﬃﬃﬃﬃﬃﬃﬃ
RR
p
All the QT and Tp-e intervals were measured and analyzed
by one of the authors, who was blinded to the group allocation.
Hemodynamic parameters including mean arterial pres-
sure (MAP) and HR were collected at the same 9 separate time
points as those for the QT and Tp-e intervals. EtCO2 and end-
tidal sevoflurane concentrations were recorded at 7 separate
time points from 10 minutes after tracheal intubation until the
end of surgery. Hypotension (MAP <60 mm Hg) and brady-
cardia (HR <40 beats/min) were treated with intravenous ephe-
drine at 4-mg increments and atropine 0.5 mg, respectively. The
CO2 insufflator was used to create a 20 mm Hg intraabdominal
pressure in the supine position. Then, intraabdominal pressure
was reduced to 15 mm Hg and maintained during the 298
Trendelenburg position.
Statistical Analysis
The primary outcome of this study was the evaluation of
the effect of dexmedetomidine on the QTc interval changes
during robot-assisted laparoscopic prostatectomy with steep
Trendelenburg position. In a preliminary study with 10 patients,
the mean standard deviation (SD) of the QTc intervals at
60 minutes after steep Trendelenburg position with CO2 pneu-
moperitoneum was 389.8 24.9 ms. Based on a previous study,
a 25-ms reduction in the QTc interval could be considered to be
clinically relevant.22 With a significant level of 5% and a
statistical power of 90%, 22 subjects were required in each
group. Considering a possible 10% dropout rate, 25 patients
were enrolled in each group.
All the values were expressed as mean SD, median
(range), or number of patients (proportion). Parametric data
were analyzed by using the independent t test, and nonpara-
metric data were analyzed by using the Mann–Whitney U test.
Categorical variables were evaluated by using the x2 test or
Fisher exact test when appropriate. Repeatedly measured vari-
ables such as QTc interval, Tp-e interval, MAP, HR, EtCO2, and
end-tidal sevoflurane concentration were analyzed by using a
linear mixed model with group, time, and group-by-time as
Medicine  Volume 95, Number 19, May 2016fixed effects. When the interaction of group, time, and group-
by-time showed statistical significance, a post hoc analysis was
performed with Bonferroni correction to adjust for multiple
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
comparisons. A P value of <0.05 was regarded as statistically
Medicine  Volume 95, Number 19, May 2016significant. Statistical analyses were performed by using the
SAS version 9.2 software (SAS Inc., Cary, NC) and IBM SPSS
Statistics 20 (SPSS Inc., Chicago, IL).
RESULTS
Of the 52 patients assessed for eligibility, 50 were enrolled
and randomized into 2 groups, of whom 47 (94%) completed the
study (Figure 1). Three patients were excluded from the analysis
for the following reasons: analysis was impossible because of
T-wave flattening in 2 patients in the control group and red
blood cell transfusion due to massive bleeding in 1 patient in the
dexmedetomidine group.
The patient characteristics and intraoperative variables,
except blood loss and total administered dose of remifentanil,
were similar between the 2 groups (Table 1). The total admi-
nistered dose of remifentanil was lower (548 196 vs
812 346mg; P¼ 0.003) and blood loss was less (174 110
vs 259 168mg; P¼ 0.048) in the dexmedetomidine group
than in the control group.
The QTc and Tp-e intervals from Baseline until T-off
60min are presented in Figure 2. Even though the baseline
values of QTc and Tp-e interval were similar between the 2
groups, significant intergroup differences were observed over-
time (PGroup Time¼ 0.001 and 0.014, respectively). The QTc
interval was shorter in the dexmedetomidine group than in the
control group at T-60min (378.2 4.8 vs 398.6 4.9ms; Bon-
ferroni corrected P¼ 0.039) and at T-off (385.1 4.6 vs
405.6 4.7ms; Bonferroni corrected P¼ 0.028). The Tp-e
interval was shorter in the dexmedetomidine group than in
the control group at T-off (46.7 1.2 vs 53. 2 1.3ms; Bon-
ferroni corrected P¼ 0.005) and T-off 60min (48.8 1.9 vs 57.
7 1.9ms; Bonferroni corrected P¼ 0.015). When compared
Assessed for elig
Randomized
Discontinued intervention
(Analysis was impossible due to T wave 
flattening, n=2)
Allocated to the control group (n=25)
• Received allocated intervention (n=25)
Analysed (n=23)
FIGURE 1. Consort diagram showing the flowchart.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.with its baseline value, the QTc interval was significantly
prolonged throughout all the time points in the control group,
while it was prolonged only after T-90min in the dexmedeto-
midine group. In Tp-e interval, no significant change was
observed in the control group, but a significant reduction
was observed in the dexmedetomidine group during the
Trendelenburg position.
None of the patients had a QTc interval of>450ms before
surgery. However, 2 patients in the control group presented a
QTc interval of >450ms, which developed after T-90min.
Twenty-two patients (96%) in the control group and 13
(54%) in the dexmedetomidine group had a QTc interval
prolongation of >20ms from the baseline value during surgery
(P¼ 0.001). The maximum QTc interval prolongation from the
baseline value during surgery was 46 21ms in the control
group and 24 21ms in the dexmedetomidine group
(P¼ 0.001; Table 2).
No significant difference in MAP and HR were observed
throughout all the time points between the 2 groups (Figure 3).
The total administered dose of ephedrine was also similar
between the groups (Table 1), and none of the patients in either
group required atropine administration. The EtCO2 during
surgery was comparable between the 2 groups, and end-tidal
sevoflurane concentration was lower in the dexmedetomidine
group than in the control group at the end of surgery (P¼ 0.049;
Table 3).
DISCUSSION
This prospective randomized, double-blind, placebo-con-
trolled trial was the 1st study regarding the effect of dexme-
detomidine on QTc and Tp-e intervals during robot-assisted
Dexmedetomidine Effect on QTc During Robotic Prostatectomylaparoscopic prostatectomy with steep Trendelenburg position.
Dexmedetomidine administration at a rate of 0.3mg/kg/hour
until the end of the Trendelenburg position attenuated the
n=64)ibility (n 52)
 (n=50)
Excluded (n=2)
• Declined to participate (n=2)
Analysed (n=24)
Allocated to the dexmedetomidine group (n=25)
• Received allocated intervention (n=25)
Discontinued intervention
(Blood transfusion due to massive bleeding, n=1)
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TABLE 1. Patient Characteristics and Intraoperative Variables
Control (n¼ 23) Dexmedetomidine (n¼ 24) P Value
Age, years 66 8 65 7 0.543
Height, cm 168 5 169 6 0.456
Weight, kg 69 7 68 10 0.648
ASA physical status, I/II 8/15 11/13 0.445
Hypertension 15 (65%) 12 (50%) 0.297
Diabetes mellitus 4 (17%) 4 (17%) 0.948
Duration of surgery, minute 169 28 167 26 0.776
Duration of pneumoperitoneum, minute 141 26 138 23 0.628
Fluid intake, mL 1933 428 1931 354 0.991
Blood loss, mL 259 168 174 110 0.048
Urine output, mL 418 218 457 258 0.581
Administered dose of remifentanil, mg 812 346 548 196 0.003
Administered dose of ephedrine, mg 6.8 8.9 5.0 8.7 0.487
Administered volume of the study drug, mL 15.2 3.1 14.5 3.0 0.403
Time to extubation, minute 7.3 3.6 7.7 3.7 0.658
Data are presented as mean standard deviation (SD) or number of pati
30
35
40
45
50
55
60
65
70
Control
Dexmedetomine
† †
† † †
† † †
††*,††*
*,†† † † *
Tp
-e
in
te
rv
al
 (m
s)
 
300
320
340
360
380
400
420
440
Control
Dexmedetomine
Q
Tc
 in
te
rv
al
 (m
s)
A
B
FIGURE 2. The QTc interval (A) and Tp-e interval (B) from prior
induction until 60 minutes after CO2 desufflation in the dexme-
detomidine and control groups. Baseline¼before induction of
anesthesia in the supine position, Intu-10 min¼10 minutes
after tracheal intubation, T-on¼ immediately after steep
Trendelenburg position with CO2 pneumoperitoneum,
T-30 min, T-60 min, and T-90 min¼30, 60, and 90 minutes after
steep Trendelenburg position with CO2 pneumoperitoneum,
T-off¼ immediately after a supine position with CO2 desufflation,
Surgery end¼ end of surgery, and T-off 60 min¼60 minutes after
a supine position with CO2 desufflation in the post-anesthetic care
unit. Data are expressed as mean SD. P<0.05, versus the
control group (Bonferroni corrected), yP<0.05, versus the base-
line value for each group (Bonferroni corrected). CO2¼ carbon
dioxide, QTc¼heart rate-corrected QT, Tp-e¼Tpeak–Tend,
SD¼ standard deviation.
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4 | www.md-journal.comQTc interval prolongation induced by CO2 pneumoperitoneum
with steep Trendelenburg position. Furthermore, the Tp-e
intervals during the Trendelenburg position, when compared
with the baseline values, were reduced significantly by dexme-
detomidine.
The abnormality of ventricular repolarization, which can
be detected on ECG as a prolonged QTc interval, is a well-
recognized cause of potentially life-threatening ventricular
arrhythmias.11,12 Many exogenous factors can lead to QTc
interval prolongation, such as medications, electrolyte imbal-
ance, and sympathetic stimulation.15 During laparoscopic
surgery, sympathetic stimulation can be induced by intraper-
itoneal CO2 insufflation, which leads to increased intraabdom-
inal pressure, hypercarbia, and increased catecholamine and
vasopressin.1–5 In particular, robot-assisted laparoscopic pros-
tatectomy requires a steep Trendelenburg position with often
long insufflation times, which may aggravate sympathetic
stimulation and consequently cause the prolongation of QTc
intervals.7 Robot-assisted laparoscopic prostatectomy has
gained popularity during the past decade and widely replaced
conventional open prostatectomy in many institutions because it
was associated with reduced blood loss, less postoperative pain,
and shorter hospital stay.24 However, several complications
resulted from stimulation of sympathetic activity, such as
increased intraocular pressure and significant cardiovascular
and respiratory changes.7,8,25 In addition, most patients who
undergo robot-assisted laparoscopic prostatectomy are elderly
with various comorbidities, which may render the patients more
vulnerable to abnormalities of ventricular repolarization caused
by sympathetic stimulation.18 Aging is well recognized to be
related with structural and functional changes of the cardio-
vascular system and torsades de pointes due to QTc interval
prolongation, which may develop more easily in patients aged
>65 years.26 The mean age of the patients in our study was
around 65 years. None of our patients had a QTc interval of
>450ms before surgery. However, in the control group, the
QTc interval was significantly increased after pneumoperito-
ents (proportion).neum with steep Trendelenburg position, which led to a QTc
interval of >450ms in 2 patients and a QTc interval pro-
longation of >20ms from baseline in 22 patients (96%). As
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 2. Changes in QTc Interval During Surgery
Control (n¼ 23) Dexmedetomidine (n¼ 24) P Value
QTc interval >450ms 2 (9%) 0 0.525
QTc interval prolongation of >20ms from the baseline value 22 (96%) 13 (54%) 0.001
. QT
Medicine  Volume 95, Number 19, May 2016 Dexmedetomidine Effect on QTc During Robotic Prostatectomya QTc interval of >450ms in men is considered prolonged and
prolongation of>20ms from the baseline value can increase the
risk of torsade de pointes,15 more attention may be needed to
prevent or attenuate QTc interval prolongation during robot-
assisted laparoscopic prostatectomy, even when preoperative
ECG findings are normal. Furthermore, as the QTc interval
prolongation did not return to the baseline values until 60min-
utes after CO2 desufflation, careful observation may be needed
even after surgery.
Several trials with opioids, b-adrenergic blockers, or local
Maximum QTc interval prolongation from the baseline value, ms
Data are presented as meanSD or number of patients (proportion)anesthetics have been conducted to attenuate QTc interval
prolongation that results from sympathetic changes during
laparoscopy and tracheal intubation. However, results are
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FIGURE 3. The mean arterial pressure (A), heart rate (B) from prior
to induction until 60 min after CO2 desufflation in the dexmede-
tomidine and control groups. Baseline¼before induction of
anesthesia in the supine position, Intu-10 min¼10 minutes after
tracheal intubation, T-on¼ immediately after steep Trendelen-
burg position with CO2 pneumoperitoneum, T-30 min, T-
60 min, and T-90 min¼30, 60, and 90 minutes after steep Tren-
delenburg position with CO2 pneumoperitoneum, T-off -
¼ immediately after a supine position with CO2 desufflation,
Surgery end¼ end of surgery, and T-off 60 min¼60 minutes after
a supine position with CO2 desufflation in the postanesthetic care
unit. Data are expressed as mean SD. yP<0.05, versus the
baseline value for each group (Bonferroni corrected).
CO2¼ carbon dioxide, SD¼ standard deviation.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.inconsistent and controversial.27–32 Dexmedetomidine, a highly
selective a-2 adrenoreceptor agonist, has sympatholytic, seda-
tive, and analgesic properties and does not induce respiratory
depression.19 In addition to these well-known properties, dex-
medetomidine has antiarrhythmic property, and perioperative
use of dexmedetomidine was effective in the prevention and
treatment of perioperative supraventricular and ventricular
arrhythmias after congenital cardiac surgery.20,21 Moreover,
QTc interval prolongation during tracheal intubation and spinal
anesthesia was attenuated by dexmedetomidine adminis-
tration.22,23 Consistent with previous results, dexmedetomidine
significantly attenuated the QTc interval prolongation during
pneumoperitoneum with steep Trendelenburg position. Signifi-
cantly fewer patients in the dexmedetomidine group showed a
QTc interval prolongation of >20ms from the baseline value
(54% vs 96% in the control group). Compared with the control
group, the dexmedetomidine group had a significantly shorter
maximumQTc interval prolongation from the baseline (24 21
vs 46 21 seconds). Even though the total administered remi-
fentanil dose was significantly lower in the dexmedetomidine
group (548 196 vs 812 346mg in the control group), the
QTc interval prolongation was significantly shorter in the
dexmedetomidine group than in the control group. This may
imply that dexmedetomidine is more powerful in attenuating
QTc interval prolongation than remifentanil, although remifen-
tanil has been known to be effective for attenuating QTc interval
prolongation as well.31,32
Tp-e interval was measured as a secondary outcome, which
reflects the transmural dispersion of ventricular repolarization
and has been regarded as a more reliable indicator of risk of
torsades de pointes.13,14 For Tp-e interval measurement, left
precordial leads (V5 and V6) should be selected because they
can measure the electrical activity of the left ventricle and
reflect the transmural dispersion of repolarization more accu-
rately, whereas bipolar limb leads (I, II, and III) could not detect
across the ventricular wall.33 Hence, previous studies also used
V5 for both QTc and Tp-e interval measurements.14,17 The Tp-e
interval in the control group was not significantly prolonged
during surgery. However, dexmedetomidine significantly
reduced the Tp-e interval from its baseline value, which could
confirm the antiarrhythmic property of dexmedetomidine. The
possible mechanisms for this antiarrhythmic property of dex-
medetomidine are as follows: a parasympathomimetic effect
that alters the Ca2þ current across the myocyte cell membrane,
which in turn induces prolonged repolarization, and a central
sympatholytic effect.26
This study has several limitations. First, whether the
effects of dexmedetomidine on ECG changes are dose-depen-
dent remains to be clarified, as we only used a continuous
infusion at a rate of 0.3mg/kg/hour without a loading dose.
46 21 24 21 0.001
c¼ heart rate-corrected QT, SD¼ standard deviation.However, as dexmedetomidine can induce bradycardia and
hypotension via sympatholytic effects,19 a higher dose may
result in hemodynamic instability, especially in elderly patients.
www.md-journal.com | 5
TABLE 3. End-Tidal Carbon Dioxide and Sevoflurane Concentrations During Surgery
Time points Control (n¼ 23) Dexmedetomidine (n¼ 24)
End-tidal CO2, mmHg Intu-10min 36 2 37 2
T-on 36 2 37 2
T-30min 38 5 38 2
T-60min 38 3 39 2
T-90min 38 3 38 3
T-off 41 3 41 4
Surgery end 36 2 37 3
End-tidal sevoflurane, vol% Intu-10min 1.2 0.3 1.3 0.3
T-on 1.6 0.3y 1.6 0.3y
T-30min 1.6 0.2y 1.6 0.2y
T-60min 1.6 0.2y 1.6 0.1y
T-90min 1.6 0.2y 1.5 0.1y
T-off 1.6 0.2y 1.5 0.1y
Surgery end 1.5 0.1y 1.4 0.2
Data are presented as meanSD. Intu-10min¼ 10 minutes after tracheal intubation, T-on¼ immediately after steep Trendelenburg position with
CO2 pneumoperitoneum, T-30min, T-60min, and T-90min¼ 30, 60, and 90 minutes after steep Trendelenburg position with CO2 pneumoper-
itoneum, T-off¼ immediately after a supine position with CO2 desufflation, Surgery end¼ end of surgery, CO2¼ carbon dioxide, SD¼ standard
Kim et al Medicine  Volume 95, Number 19, May 2016Moreover, dexmedetomidine produces transient hypertension
when administered as a loading dose.19 Thus, a low-dose
continuous infusion may be proper when considering patient
age and hemodynamic changes during pneumoperitoneum.
Second, measurement of HR variability or plasma catechol-
amine, which would be a useful assessment tool for baseline
sympathetic activity, was not performed. However, we could
indirectly infer that the sympathetic activities of the patients in
the 2 groups were similar, as the baseline HR, MAP, and QTc
interval were comparable. Lastly, more than 50% of the patients
had hypertension or diabetes mellitus, which can influence the
ECG changes during pneumoperitoneum. However, owing to
the high prevalence of hypertension and diabetes mellitus in the
elderly population, the results of this study could be well
attributed to common clinical settings.
In conclusion, continuous infusion of dexmedetomidine at
a rate of 0.3mg/kg/hour until the end of the Trendelenburg
position significantly attenuated the QTc interval prolongation
induced by CO2 pneumoperitoneum with steep Trendelenburg
position during robot-assisted laparoscopic prostatectomy.
Furthermore, dexmedetomidine reduced the Tp-e interval.
Therefore, dexmedetomidine administration may be effective
for patients susceptible to the development of ventricular
arrhythmia during robot-assisted laparoscopic prostatectomy.
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